The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
We aim to assess the the efficiency and safety of N-acetylcysteine for prevention of
thrombotic events after allogenic hematopoietic stem cell transplantation.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University